MMP12 and Hepatic fibrosis: This feedback loop may help our understanding of the self-aggravating process of liver fibrosis and the therapeutic mechanisms of MSCs and TSG-6 (Fig. 5I): Persisted inflammation produces a great number of inflammatory activators, which suppress MMP12 and its antifibrotic effects, leading fibrosis to progress.